Lack of Awareness of Own Hypercholesterolemia or Statin Medication among Adult Statin Users in the United States
Prevalence and Patient Characteristics in a Repeated Cross-Sectional Study
Bibliographic Data
| ID | 15467102 |
|---|---|
| Authors | Kenjiro Imai (National Center for Global Health and Medicine), Takehiro Sugiyama (0000-0001-5391-682X, National Center for Global Health and Medicine), Mitsuru Ohsugi (0000-0002-3222-8507, National Center for Global Health and Medicine), Masafumi Kakei (Niigata Prefectural Niigata Minami High School), Kazuo Hara (0000-0002-4699-6136, Jichi Medical University Saitama Medical Center, corresponding author) |
| Year | 2022 |
| Volume | 19 |
| Issue | 10 |
| Pages | 6099-6099 |
| Publication date | 2022-05-17 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Environmental Research and Public Health (JOURNAL) |
| Journal identifiers | ISSN: 1661-7827 • E-ISSN: 1660-4601 |
| Publisher | Multidisciplinary Digital Publishing Institute (PUBLISHER • CH) |
| DOI | 10.3390/ijerph19106099 |
| PMID | 35627634 |
| OpenAlex | W4280586206 |
| Language | EN |
| References cited | 21 |
Knowledge of a patient’s medication is important in treating hyperlipidemia; however, little is known about this in practice. We carried out a repeated cross-sectional study to analyze a nationally representative sample of US adult statin users from the National Health and Nutrition Examination Survey, 1999−2018. We used medication bottle checks and self-reported survey data to estimate the percentage of individuals who are unaware of their hypercholesterolemia, type of medication, or how to take their medication. We used logistic regression to examine their characteristics. We included 8798 statin users; however, 17.6% were unaware of their hypercholesterolemia or statin use. Being older, male, non-Hispanic Black, taking a wider range of prescription medications, and previous diabetes or cardiovascular disease diagnosis were associated with lack of awareness. Serum low-density lipoprotein cholesterol level was lower among those lacking awareness (85.5 vs. 100.7 mg/dL; p 75 years old. Roughly one in six lacked awareness, but no association was found with hypercholesterolemia control. Healthcare providers should ascertain a patient’s understanding and consider the risks and benefits of statin medication
Cholesterol · Cross-sectional study · Diabetes mellitus · Disease · Environmental health · Familial hypercholesterolemia · Family medicine · Hyperlipidemia · Logistic regression · Medical prescription · National Health and Nutrition Examination Survey · Population · Statin · Type 2 diabetes · Lipoproteins and Cardiovascular Health · Medicine · Pharmaceutical Economics and Policy · Pharmaceutical Practices and Patient Outcomes · Internal Medicine · Pharmacology
| Highly cited | No |
|---|